1800-272-662
Shopping Cart 0
countryflagAU
Login

Bcal Diagnostics Ltd

Healthcare AU BDX

0.1AUD
-0.015(13.04%)

Last update at 2026-03-13T04:51:00Z

Day Range

0.100.12
LowHigh

52 Week Range

0.050.15
LowHigh

Fundamentals

  • Previous Close 0.12
  • Market Cap42.40M
  • Volume1179889
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.41186M
  • Revenue TTM2.54M
  • Revenue Per Share TTM0.007
  • Gross Profit TTM 2.54M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -7.24104M -9.44690M -5.06176M -3.38549M -1.52497M
Minority interest - - - - -
Net income -7.24104M -6.40019M -5.06176M -3.38549M -1.52497M
Selling general administrative 5.12M 1.64M 3.27M 1.87M 0.55M
Selling and marketing expenses 0.27M 0.24M - 0.13M -
Gross profit 0.02M 3.10M - - -
Reconciled depreciation 1.00M 0.58M 0.11M 0.02M -
Ebit -7.19531M -6.02697M -4.72515M -3.91451M -0.93392M
Ebitda -6.19335M -5.66681M -7.78479M -3.89390M -
Depreciation and amortization 1.00M 0.36M - 0.02M -
Non operating income net other - - - - -
Operating income -9.96233M -5.44719M -5.10787M -3.91451M -1.52522M
Other operating expenses 9.98M 8.55M - 3.91M -
Interest expense 0.09M 0.10M - 0.00000M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.18M 0.05M 0.05M 0.02M 0.00025M
Net interest income 0.09M -0.04854M 0.05M 0.02M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -2.62870M -3.04671M - -0.01864M -
Total revenue 0.02M 3.10M 2.79M 0.72M 0.28M
Total operating expenses 9.98M 8.55M - 3.91M -
Cost of revenue - 0.58M - - -
Total other income expense net 2.72M -3.99971M 2.79M 0.51M -
Discontinued operations - - - - -
Net income from continuing ops -7.24104M -6.40019M -5.06175M -3.38549M -
Net income applicable to common shares -7.24104M -6.40019M -5.06175M -3.38549M -1.52497M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 9.91M 12.27M 8.37M 10.59M 4.13M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - 0.08M -0.00000M 4.00M 0.13M
Total liab 3.69M 3.68M 3.16M 0.95M 0.53M
Total stockholder equity 6.22M 8.59M 5.21M 9.64M 3.61M
Deferred long term liab - - - - -
Other current liab - 1.13M 0.04M 0.67M 0.01M
Common stock - 28.90M 19.28M 18.87M 9.46M
Capital stock 33.83M - 19.28M 18.87M -
Retained earnings -28.08129M -20.97596M -14.61492M -9.55317M -6.16768M
Other liab - - 0.00000M - -
Good will - - - - -
Other assets - 0.00000M - - -
Cash 4.52M 6.47M 3.17M 5.57M 3.41M
Cash and equivalents - - - - -
Total current liabilities 3.11M 2.60M 2.26M 0.95M 0.53M
Current deferred revenue - 0.28M - - -
Net debt - -4.94914M - -5.57142M -
Short term debt - 0.44M 0.00000M 0.00000M 0.00000M
Short long term debt 1.58M - - - -
Short long term debt total - 1.52M - - -
Other stockholder equity - - 0.55M 0.32M 0.32M
Property plant equipment - - 2.17M 0.14M 0.00385M
Total current assets 7.20M 9.34M 6.20M 10.46M 4.13M
Long term investments - - - - -
Net tangible assets - - 5.21M 9.64M 3.61M
Short term investments - - 0.00000M 4.00M -
Net receivables - 2.78M 2.69M 0.01M 0.35M
Long term debt 0.12M - - 0.00000M 0.00000M
Inventory - - - - -
Accounts payable 0.55M 0.74M 1.58M 0.28M 0.25M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.67M - 0.32M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - -0.00000M - - -
Deferred long term asset charges - - - - -
Non current assets total 2.71M 2.93M 2.17M 0.14M -
Capital lease obligations 0.68M - 1.06M - -
Long term debt total - - 0.90M 0.00000M 0.00000M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -0.78768M -1.15095M 4.00M -4.00000M -4.00000M
Change to liabilities - - 0.78M 0.05M 0.44M
Total cashflows from investing activities -0.78768M -1.15095M 3.64M -4.02576M -0.00385M
Net borrowings 1.08M -0.25688M -0.03676M -0.03676M -0.03676M
Total cash from financing activities 4.97M 8.97M 0.01M 9.41M 4.20M
Change to operating activities - - - - -
Net income -7.24104M -6.40019M -5.06175M -3.38549M -1.52497M
Change in cash -1.95023M 3.30M -2.39732M 2.16M 2.99M
Begin period cash flow 6.47M 3.17M 5.57M 3.41M -
End period cash flow 4.52M 6.47M 3.17M 5.57M 3.41M
Total cash from operating activities -6.13589M -4.52309M -6.04809M -3.21932M -1.20642M
Issuance of capital stock 4.30M 9.85M 0.05M 10.03M -
Depreciation - 0.58M 0.11M 0.02M 0.02M
Other cashflows from investing activities - - 4.00M -4.00000M -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.19M 0.16M -2.14255M -0.28884M -0.31767M
Sale purchase of stock -0.11501M -0.44483M 0.05M -0.62179M 4.41M
Other cashflows from financing activities -0.29457M -0.17885M 0.00000M -4.02576M -0.20835M
Change to netincome - - 0.27M 0.38M 0.19M
Capital expenditures 0.79M 1.15M 0.36M 4.03M 0.00385M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.57310M 0.61M 1.04M 0.29M 0.40M
Stock based compensation - 0.57M - - -
Other non cash items -5.56278M 0.11M - - -
Free cash flow -6.92356M -5.67403M -6.04809M -4.02576M -

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BDX
Bcal Diagnostics Ltd		 -0.015 13.04% 0.10 - - 16.71 16.97 1942.24 -1.8009
SHL
Sonic Healthcare Ltd		 0.09 0.43% 21.20 19.10 15.48 1.01 1.22 1.52 8.99
IDX
Integral Diagnostics Ltd		 0.01 0.43% 2.32 57.75 15.80 1.12 1.30 1.89 12.08
HLS
Healius Ltd		 - -% 0.59 - 26.25 0.32 0.78 0.96 10.14
ACL
Australian Clinical Labs Ltd		 -0.02 0.97% 2.05 14.79 12.17 0.54 2.75 0.96 3.92

Reports Covered

Stock Research & News

View All

Profile

BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTESTplus, a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening. The company also develops BREASTEST, BCAL Diagnostics, and BCAL Dx. The company was incorporated in 2010 and is headquartered in Sydney, Australia.

Bcal Diagnostics Ltd

50 Clarence Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Ms. Jayne Andrea Shaw Co-Founder & Exec. Chairman NA
Dr. John G. Hurrell B.Sc, Fulbright Fel, M.Sc(Qual), Ph.D. Chief Exec. Officer NA
Hon. Ronald Anthony Phillips A.O. Co-Founder & Non-Exec. Director NA
Dr. Amani Batarseh Ph.D. Chief Scientist Officer NA
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), C.A., CA, MAICD CFO & Company Sec. 1954
Dr. Jane Ryan Bsc (Hons), M.A.I.C.D., Ph.D. Chief Operating Officer 1959
Sean Kennedy Director of Corp. Fin. NA
Ms. Rebecca Shaw Marketing Mang. NA
Ms. Jayne Andrea Shaw Co-Founder & Executive Chairman NA
Ms. Jayne Andrea Shaw Co-Founder & Executive Chairman NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.